Hui Yu

11PUBLICATIONS
31CO-AUTHORS
Predictive and prognostic markersOther creative arts and writing not elsewhere classifiedPharmacogenomicsCancer geneticsComputational complexity and computability
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Feb 27, 2026
Prediction Analysis of Microarray of 50 genes (PAM50) classifier validated for predicting prostate cancer progression in active surveillance: Miami Active Surveillance Trial (MAST).

Ankur Malpani, Jonathan T Ryan, Hui Yu

|Jul 22, 2025
Reply by Authors.

Pedro F S Freitas, Archan Khandekar, Joao G Porto

|Jun 20, 2025
Can Genomic Classifiers in Biopsy Cores With Grade Group 1 Cancer Predict Higher-Grade Disease Elsewhere in the Prostate? Results From the Prospective Miami Active Surveillance Trial.

Pedro F S Freitas, Archan Khandekar, Joao G Porto

|Jul 27, 2022
Drug-Target Network Study Reveals the Core Target-Protein Interactions of Various COVID-19 Treatments.

Yulin Dai, Hui Yu, Qiheng Yan

|May 28, 2022
A Novel Strategy to Identify Prognosis-Relevant Gene Sets in Cancers.

Junyi Pu, Hui Yu, Yan Guo

|Jan 21, 2022
Comprehensive Analysis of Co-Mutations Identifies Cooperating Mechanisms of Tumorigenesis.

Limin Jiang, Hui Yu, Scott Ness

Pageof 2

Frequent Collaborators

3 joint publications

Scott Ness

3 joint publications

Yan Guo

2 joint publications

Joao G Porto

2 joint publications

Oleksandr N Kryvenko